Find an expert
Our panel of editors and experts are available for interview
Ian Mulvany
Chief Technology Officer, BMJ Group
Since joining BMJ Group in 2020 during the pandemic, Ian has led a sweeping digital transformation, strengthening the organisation’s infrastructure, accelerating its adoption of cloud-based platforms, and embedding AI and automation to improve delivery. Ian has a long track record of driving innovation in research technology. At SAGE Publishing, he founded SAGE Ocean, an incubator advancing new methods for social science research using big data. Earlier roles include Head of Technology at eLife Sciences, Head of Product at Mendeley, and Product Manager at Nature Publishing Group. He has also consistently advocated for open science, serving on the board of Dryad and the editorial board of the Journal of Open Research Software.
A recognised thought leader on digital transformation and AI in publishing, Ian has spoken at The London Book Fair, ALPSP, STM Week, and the International Association of Scientific, Technical and Medical Publishers (STM), as well as in podcasts and webinars on the future of open research, data, and AI adoption.
He regularly shares his reflections on technology, research, and innovation on his personal blog: mulvany.net
.
Gareth Iacobucci
Assistant News Editor, The BMJ
Gareth Iacobucci reports mostly on issues of interest to doctors in the UK. He joined The BMJ in 2012. Prior to this Gareth was a reporter and editor at the general practioners’ title Pulse for five years.
Theodora Bloom
Executive Editor of the BMJ
Theodora Bloom is executive editor of The BMJ. At the BMJ, Theo’s responsibilities include publishing, business, platform and operations as well as ethical and policy matters. She is a Co-Founder of the medRxiv preprint server, a collaboration between BMJ, Cold Spring Harbor Laboratory and Yale University, and jointly coordinates open access and open research initiatives at BMJ.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
Professor Juan Víctor Ariel Franco
Editor-in-Chief of BMJ Evidence-Based Medicine
Professor Juan Franco is a family doctor at the Hospital Italiano de Buenos Aires, Argentina, and Vice-chair of the Research Department at the Instituto Universitario Hispital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre. He is a professor at IUHI and Universidad Nacional de La Matanza, and editor for the Cochrane Urology Group and a member of Cochrane’s Governing Board.
